• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

COUNTERPOINT: In the Era of Cystic Fibrosis Transmembrane Regulator Protein Modulator Therapy, Are the Treatment Goals for Adults Now Different From Those for Children With Cystic Fibrosis? No.

作者信息

Thursfield Rebecca M, Shafi Nadia, Davies Jane C

机构信息

Alder Hey Children's NHS Foundation Trust, Liverpool, England.

Barts Health NHS Trust, London, England.

出版信息

Chest. 2022 Jan;161(1):21-24. doi: 10.1016/j.chest.2021.06.018.

DOI:10.1016/j.chest.2021.06.018
PMID:35000702
Abstract
摘要

相似文献

1
COUNTERPOINT: In the Era of Cystic Fibrosis Transmembrane Regulator Protein Modulator Therapy, Are the Treatment Goals for Adults Now Different From Those for Children With Cystic Fibrosis? No.反驳观点：在囊性纤维化跨膜调节蛋白调节剂治疗时代，成人囊性纤维化的治疗目标与儿童现在有所不同吗？没有。
Chest. 2022 Jan;161(1):21-24. doi: 10.1016/j.chest.2021.06.018.
2
A New Era for Cystic Fibrosis and Cystic Fibrosis Transmembrane Conductance Regulator Modulator Trials in Infants.婴儿囊性纤维化及囊性纤维化跨膜传导调节因子调节剂试验的新时代。
Am J Respir Crit Care Med. 2022 Nov 15;206(10):1193-1195. doi: 10.1164/rccm.202207-1356ED.
3
Cystic fibrosis transmembrane conductance regulator biomarkers in 'real life': can we evaluate individual efficacy of cystic fibrosis transmembrane conductance regulator therapy?“现实生活”中的囊性纤维化跨膜传导调节因子生物标志物：我们能否评估囊性纤维化跨膜传导调节因子疗法的个体疗效？
Ther Adv Respir Dis. 2015 Aug;9(4):198-200. doi: 10.1177/1753465815579364.
4
Combination CFTR modulator therapy in children and adults with cystic fibrosis.囊性纤维化儿童和成人的联合CFTR调节剂治疗
Lancet Respir Med. 2021 Jul;9(7):677-679. doi: 10.1016/S2213-2600(21)00176-4. Epub 2021 May 6.
5
SIMPLIFYing cystic fibrosis treatment in a post-modulator era.在后调节剂时代简化囊性纤维化治疗
Lancet Respir Med. 2023 Apr;11(4):299-300. doi: 10.1016/S2213-2600(22)00480-5. Epub 2022 Dec 1.
6
Evidence for Early Cystic Fibrosis Transmembrane Conductance Regulator Modulator Treatment for Children with Cystic Fibrosis Keeps Growing.早期使用囊性纤维化跨膜传导调节因子调节剂治疗囊性纤维化儿童的证据不断增加。
Am J Respir Crit Care Med. 2022 Dec 1;206(11):1308-1310. doi: 10.1164/rccm.202208-1507ED.
7
A Review on the Use of Cystic Fibrosis Transmembrane Conductance Regulator Gene Modulators in Pediatric Patients.囊性纤维化跨膜电导调节因子基因调节剂在儿科患者中的应用综述。
J Pediatr Health Care. 2019 May-Jun;33(3):356-364. doi: 10.1016/j.pedhc.2018.08.013.
8
Therapy for cystic fibrosis--the end of the beginning?囊性纤维化的治疗——开端的结束？
N Engl J Med. 2011 Nov 3;365(18):1734-5. doi: 10.1056/NEJMe1110323.
9
The Future of Highly Effective Modulator Therapy in Cystic Fibrosis.囊性纤维化中高效调节剂疗法的未来
Am J Respir Crit Care Med. 2021 Jun 15;203(12):1453-1455. doi: 10.1164/rccm.202104-0850ED.
10
Targeting the basic defect in cystic fibrosis.针对囊性纤维化的基本缺陷。
N Engl J Med. 2010 Nov 18;363(21):2056-7. doi: 10.1056/NEJMe1010123.